 |
|
|
| |
A Comprehensive Assessment of Hepatobiliary Disorders in HIV-Infected Patients Treated With Dolutegravir, Elvitegravir, Raltegravir or Darunavir in the OPERA Database - Liver Chemistry Elevations/DILI
|
| |
| |
Reported by Jules Levin
22nd International AIDS Conference (AIDS 2018), Amsterdam, Netherlands, 23-27 July 2018
Michael Wohlfeiler,1 Karam Mounzer,2 Laurence Brunet,3 Jennifer Fusco,3 Vani Vannappagari,4 Lloyd Curtis,5
Nassrin Payvandi,5 Michael Aboud,6 Ricky Hsu,7,8 Philip Lackey,9 Gregory Fusco3
1AIDS Healthcare Foundation, Miami, FL, USA; 2Philadelphia FIGHT, Philadelphia, PA, USA; 3Epividian, Inc., Durham, NC, USA; 4ViiV Healthcare, Research Triangle Park, NC, USA; 5GlaxoSmithKline, London, UK; 6ViiV Healthcare, London, UK; 7AIDS Healthcare Foundation, New York, NY, USA; 8NYU Langone Medical Center, New York, NY, USA;
9Carolinas Healthcare System, Charlotte, NC, USA
|
| |
|
|
|
|
|
